NBIG Performance — Leverage Shares 2X Long NBIS Daily ETF

Data updated: 2026-09-28

In the 12 months to Jul 2026 the fund took in a net $84.5M, and assets reached $90.37M.

NBIG Growth of $100

What $100 invested in Leverage Shares 2X Long NBIS Daily ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Trading - Leveraged category average over the same months.

PeriodNBIGCategory average
Since data start (Oct 2025 – Jul 2026)$97$90

NBIG Trailing Returns

Total returns to Jul 2026, from SEC N-PORT.

PeriodTotal return
YTD+126.52%

NBIG Annual Returns

Calendar-year total returns of Leverage Shares 2X Long NBIS Daily ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.

YearTotal return
2026 (Jan–Jul)+126.52%
2025 (Oct–Dec)−57.09%

NBIG Monthly Returns

Monthly total returns as reported on SEC Form N-PORT.

YearJanFebMarAprMayJunJulAugSepOctNovDec
2026−3.4%+2.8%+14.4%+68.0%+148.7%+30.0%−63.3%—————
2025—————————+23.1%−52.2%−27.1%

NBIG Risk

Risk measures from monthly returns over Oct 2025 – Jul 2026.

  • Best month: +148.74% (May 2026)
  • Worst month: −63.28% (Jul 2026)

NBIG Fund Flows

Monthly money in and out of Leverage Shares 2X Long NBIS Daily ETF, from SEC Form N-PORT.

  • 12-month net flow: $84.5M
  • 12-month gross sales (incl. reinvestments): $220.0M
  • Sales ÷ redemptions: 1.62×
MonthSalesRedemptionsNet flow
Jul 2026$62.7M$21.9M$40.8M
Jun 2026$28.5M$22.5M$6.0M
May 2026$76.8M$52.0M$24.8M
Apr 2026$12.5M$22.2M−$9.7M
Mar 2026$13.3M$6.6M$6.7M
Feb 2026$4.7M$6.2M−$1.5M
Jan 2026$5.5M$3.4M$2.1M
Dec 2025$7.1M$0$7.1M
Nov 2025$7.3M$264K$7.1M
Oct 2025$1.6M$424K$1.1M
Sep 2025$0$0$0
Aug 2025$0$0$0

NBIG Assets Under Management

Net assets of Leverage Shares 2X Long NBIS Daily ETF by report date, from SEC N-PORT filings.

Report dateNet assets
2026-07-31$90.37M
2026-04-30$27.13M
2026-01-31$12.49M
2025-10-31$1.29M

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.